K. Stephans

发表

Assessing Feasibility of Real-Time Ultrasound Monitoring in Stereotactic Body Radiotherapy of Liver Tumors

Ping Xia, John Wong, Peng Qi, 2013, Technology in cancer research & treatment.

A Randomized Phase 2 Trial of Prophylactic Manuka Honey for the Reduction of Chemoradiation Therapy-Induced Esophagitis During the Treatment of Lung Cancer: Results of NRG Oncology RTOG 1012.

A. Dueck, T. Williams, A. Rimner, 2017, International journal of radiation oncology, biology, physics.

Report of whole-brain radiation therapy in a patient with an implanted deep brain stimulator: important neurosurgical considerations and radiotherapy practice principles.

A. Machado, R. Kotecha, J. Suh, 2016, Journal of neurosurgery.

Stereotactic Body Radiotherapy for High-Risk Localized CARcinoma of the Prostate (SHARP) Consortium: Analysis of 344 Prospectively Treated Patients.

A. Kishan, M. Steinberg, P. Kupelian, 2021, International journal of radiation oncology, biology, physics.

Heterogenous Dose-escalated Prostate Stereotactic Body Radiation Therapy for All Risk Prostate Cancer

C. Reddy, E. Klein, G. Sedor, 2020, American journal of clinical oncology.

Adjuvant versus neoadjuvant androgen deprivation with radiotherapy for prostate cancer: does sequencing matter?

C. Reddy, P. Kupelian, K. Stephans, 2015, Clinical genitourinary cancer.

Combining prior day contours to improve automated prostate segmentation.

A. Godley, K. Stephans, Lawrence J Sheplan Olsen, 2013, Medical physics.

Predicting pathologic response to neoadjuvant chemoradiation in resectable stage III non-small cell lung cancer patients using computed tomography radiomic features.

A. Madabhushi, V. Velcheti, S. Murthy, 2019, Lung cancer.

1-3 Synchronous brain metastases in newly diagnosed non-small cell lung cancer ( NSCLC ) : validation of the disease specific GPA

G. Barnett, C. Reddy, M. Vogelbaum, 2017 .

Alignment focus of daily image guidance for concurrent treatment of prostate and pelvic lymph nodes.

P. Xia, Guangshun Huang, Y. Zhong, 2013, International journal of radiation oncology, biology, physics.

Esophageal dose tolerance to hypofractionated stereotactic body radiation therapy: risk factors for late toxicity.

P. Xia, C. Reddy, T. Djemil, 2014, International journal of radiation oncology, biology, physics.

Long-Term Efficacy and Toxicity of Low-Dose-Rate ¹²⁵I Prostate Brachytherapy as Monotherapy in Low-, Intermediate-, and High-Risk Prostate Cancer.

J. Ciezki, C. Reddy, E. Klein, 2015, International journal of radiation oncology, biology, physics.

Outcomes for prostate glands >60 cc treated with low-dose-rate brachytherapy.

J. Ciezki, C. Reddy, E. Klein, 2016, Brachytherapy.

Lung cancer radiation therapy: Defining optimal evidence-based treatment approaches

G. Videtic, C. Shah, K. Stephans, 2016, Applied Radiation Oncology.

Local control for clinical stage I non-small cell lung cancer treated with 5-fraction stereotactic body radiation therapy is not associated with treatment schedule.

J. Bradley, C. Robinson, G. Videtic, 2018, Practical radiation oncology.

One versus three fractions of stereotactic body radiation therapy for peripheral stage I-II non-small cell lung cancer: a randomized, multi-institution, phase 2 trial.

Anurag K. Singh, G. Videtic, J. Bogart, 2019, International journal of radiation oncology, biology, physics.

Tumor Control and Toxicity for Common Stereotactic Body Radiation Therapy Dose-Fractionation Regimens in Stage I Non-Small Cell Lung Cancer.

T. Zhuang, C. Reddy, G. Videtic, 2018, International journal of radiation oncology, biology, physics.

Stereotactic body radiotherapy for stage I non–small cell lung cancer

K. Stephans, 2012, Cleveland Clinic Journal of Medicine.

Prediction of chest wall toxicity from lung stereotactic body radiotherapy (SBRT).

C. Reddy, T. Djemil, C. Robinson, 2009, International journal of radiation oncology, biology, physics.

Durvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD(L)-1 therapy: an open-label, multicentre, randomised, phase 2 trial.

N. Lennon, A. Giobbie-Hurder, R. Mak, 2022, The Lancet. Oncology.

Persistent Dysphagia After Induction Chemotherapy in Patients with Esophageal Adenocarcinoma Predicts Poor Post-Operative Outcomes

S. Murthy, L. Rybicki, G. Videtic, 2017, Journal of Gastrointestinal Cancer.

The relationship between pathologic nodal disease and residual tumor viability after induction chemotherapy in patients with locally advanced esophageal adenocarcinoma receiving a tri-modality regimen.

S. Murthy, L. Rybicki, G. Videtic, 2016, Journal of gastrointestinal oncology.

A Phase II Trial of Induction Epirubicin, Oxaliplatin, and Fluorouracil, Followed by Surgery and Postoperative Concurrent Cisplatin and Fluorouracil Chemoradiotherapy in Patients with Locoregionally Advanced Adenocarcinoma of the Esophagus and Gastroesophageal Junction

T. Rice, S. Murthy, L. Rybicki, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Dose calculation differences between Monte Carlo and pencil beam depend on the tumor locations and volumes for lung stereotactic body radiation therapy

P. Xia, T. Zhuang, T. Djemil, 2013, Journal of applied clinical medical physics.

SU‐E‐T‐534: Assessing Planning Margins Using Shifting Dose Matrix Method to Calculate Daily and Cumulative Doses under Imaging Guided Radiotherapy (IGRT)

P. Xia, K. Stephans, R. Tendulkar, 2011 .

Validation of the Disease‐Specific GPA for Patients With 1 to 3 Synchronous Brain Metastases in Newly Diagnosed NSCLC

G. Barnett, C. Reddy, M. Vogelbaum, 2018, Clinical lung cancer.

Lung Stereotactic Body Radiation Therapy: Regional Nodal Failure Is Not Predicted by Tumor Size

C. Reddy, G. Videtic, K. Stephans, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

The Role of PET in the Evaluation, Treatment, and Ongoing Management of Lung Cancer.

M. Machtay, K. Stephans, Anton Khouri, 2011, PET clinics.

The Role of PET in the Evaluation, Treatment, and Ongoing Management of Lung Cancer.

M. Machtay, K. Stephans, Anton Khouri, 2011, PET clinics.

Validation of the NCCN prostate cancer favorable- and unfavorable-intermediate risk groups among men treated with I-125 low dose rate brachytherapy monotherapy.

J. Ciezki, C. Reddy, E. Klein, 2019, Brachytherapy.

Salvage Stereotactic Body Radiation Therapy for Isolated Local Recurrence After Primary Surgical Resection of Non-small-cell Lung Cancer.

C. Reddy, G. Videtic, K. Stephans, 2020, Clinical lung cancer.

Long term follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): A randomized phase II study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer

Ashutosh Kumar Singh, Joe Y. Chang, H. Choy, 2019 .

A Principal Component of Quality-of-Life Measures Is Associated with Survival: Validation in a Prospective Cohort of Lung Cancer Patients Treated with Stereotactic Body Radiation Therapy

Anurag K. Singh, G. Videtic, J. Bogart, 2021, Cancers.

Immunologic response of combined interleukin-2 and stereotactic body radiotherapy

J. Miller, J. Suh, K. Stephans, 2016 .

Stereotactic Body Radiotherapy for T3N0 Lung Cancer With Chest Wall Invasion.

T. Zhuang, T. Djemil, G. Videtic, 2016, Clinical lung cancer.

Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer Tumors Greater Than 5 cm: Safety and Efficacy.

T. Djemil, G. Videtic, K. Stephans, 2015, International journal of radiation oncology, biology, physics.

Stereotactic body radiation therapy-based treatment model for stage I medically inoperable small cell lung cancer.

C. Reddy, T. Djemil, G. Videtic, 2013, Practical radiation oncology.

Synchronous non small cell lung cancer nodules treated with stereotactic body radiation therapy (SBRT).

T. Djemil, G. Videtic, Aryavarta M S Kumar, 2014, Journal of radiosurgery and SBRT.

Late toxicity after intensity modulated and image guided radiation therapy for localized prostate cancer and post-prostatectomy patients.

Kristin D. Brockway, P. Xia, J. Ciezki, 2013, Practical radiation oncology.

Safety and efficacy of salvage low-dose-rate brachytherapy for prostate bed recurrences following radical prostatectomy

J. Ciezki, C. Reddy, E. Klein, 2015, Journal of contemporary brachytherapy.

Early infectious complications with transponder placement for external beam radiation therapy for prostate cancer

E. Klein, J. Jones, R. Berglund, 2012, BJU international.

Stereotactic Body Radiotherapy for High-Risk Localized CARcinoma of the Prostate (SHARP) Consortium: Analysis of 344 Prospectively Treated Patients.

A. Kishan, M. Steinberg, P. Kupelian, 2020, International journal of radiation oncology, biology, physics.

The current status of image-guided external beam radiotherapy for prostate cancer

P. Xia, J. Ciezki, K. Stephans, 2010, Current opinion in urology.

Systematic errors in lung stereotactic body radiation therapy (SBRT): a caution on mixing and matching target delineation methods and planning CTs

P. Xia, T. Djemil, G. Videtic, 2015, Journal of Radiation Oncology.

Isolated Nodal Failure after Stereotactic Body Radiotherapy for Lung Cancer: The Role for Salvage Mediastinal Radiotherapy

G. Videtic, K. Stephans, N. Woody, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Effect of Tumor Location and Dosimetric Predictors for Chest Wall Toxicity in Single-Fraction Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer.

C. Reddy, K. Verdecchia, G. Videtic, 2019, Practical radiation oncology.

Volumetric‐based image guidance is superior to marker‐based alignments for stereotactic body radiotherapy of prostate cancer

P. Xia, A. Vassil, T. Djemil, 2018, Journal of applied clinical medical physics.

Single-Fraction Stereotactic Ablative Body Radiotherapy to the Lung - The Knockout Punch.

A. Louie, S. Harden, G. Videtic, 2022, Clinical oncology (Royal College of Radiologists (Great Britain)).

Zinc elevates neuropeptide Y levels in rat pheochromocytoma cells by a mechanism independent of L-channel mediated inhibition of release

E. M. Adler, K. Stephans, E. Adler, 2000, Brain Research.

Local Control With Single-Fraction Lung Stereotactic Body Radiotherapy is not influenced by Non-Small Cell Lung Cancer Histologic Subtype.

C. Reddy, G. Videtic, K. Stephans, 2022, Clinical lung cancer.

Never too old ” : A single-institution experience of stereotactic body radiotherapy for patients 90 years and older with early stage lung cancer

C. Reddy, G. Videtic, K. Stephans, 2017 .

MA01.03 An Externally Validated Nomogram for Predicting Distant Metastasis After SBRT for Early Stage Non-Small Cell Lung Cancer

M. Kattan, J. Bradley, C. Robinson, 2018, Journal of Thoracic Oncology.

Management of Oligometastatic Prostate Cancer.

J. Broughman, O. Mian, K. Stephans, 2020, Applied radiation oncology.

Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical Trial.

L. Minasian, E. Basch, A. Bennett, 2017, International journal of radiation oncology, biology, physics.

Dose differences in intensity‐modulated radiotherapy plans calculated with pencil beam and Monte Carlo for lung SBRT

Han Liu, P. Xia, T. Zhuang, 2015, Journal of applied clinical medical physics.

Heart rate recovery and survival in patients undergoing stereotactic body radiotherapy for treatment of early-stage lung cancer.

P. Mazzone, G. Videtic, Humberto K. Choi, 2015, Journal of radiosurgery and SBRT.

Intriguing, but Not the Right Setting.

R. Kotecha, K. Stephans, 2017, International journal of radiation oncology, biology, physics.

A Phase 1 Study of Concurrent Neoadjuvant Pembrolizumab Plus Chemoradiation Followed by Consolidation Pembrolizumab in Patients With Resectable Stage IIIA NSCLC

V. Velcheti, G. Videtic, Christopher A. Lemmon, 2022, JTO clinical and research reports.

Redefining high-risk prostate cancer based on distant metastases and mortality after high-dose radiotherapy with androgen deprivation therapy.

J. Ciezki, C. Reddy, E. Klein, 2012, International journal of radiation oncology, biology, physics.

Practical considerations of single-fraction stereotactic ablative radiotherapy to the lung.

Ashutosh Kumar Singh, B. Slotman, A. Louie, 2022, Lung cancer.

Relationship of imaging frequency and planning margin to account for intrafraction prostate motion: analysis based on real-time monitoring data.

P. Xia, K. Stephans, A. Magnelli, 2013, International journal of radiation oncology, biology, physics.

IGRT in Prostate Cancer—the Calypso 4D Localization System

A. Mahadevan, T. Djemil, K. Stephans, 2008 .

Dose-Escalated Stereotactic Body Radiation Therapy for Patients With Intermediate- and High-Risk Prostate Cancer: Initial Dosimetry Analysis and Patient Outcomes.

C. Reddy, E. Klein, R. Kotecha, 2016, International journal of radiation oncology, biology, physics.

125I Interstitial brachytherapy with or without androgen deprivation therapy among unfavorable-intermediate and high-risk prostate cancer.

J. Ciezki, C. Reddy, E. Klein, 2021, Brachytherapy.

Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma

J. Fung, F. Aucejo, M. Abdel-Wahab, 2015, Digestive Disease Interventions.

30 Gy or 34 Gy? Comparing 2 single-fraction SBRT dose schedules for stage I medically inoperable non-small cell lung cancer.

T. Zhuang, C. Reddy, T. Djemil, 2014, International journal of radiation oncology, biology, physics.

Time Will Tell: Is 60 Gy in 3 Fractions the Optimal SBRT Schedule for Stage I Non-Small Cell Lung Cancer?

C. Reddy, T. Djemil, G. Videtic, 2014 .

Differential Distribution and Function of Hyperpolarization-Activated Channels in Sensory Neurons and Mechanosensitive Fibers

M. Andresen, P. Glazebrook, A. Ramirez, 2004, The Journal of Neuroscience.

Early-Stage Non–Small-Cell Lung Cancer

G. Videtic, K. Stephans, S. Kilic, 2021, Essentials of Clinical Radiation Oncology.

A Histologic Basis for the Efficacy of SBRT to the lung

P. Xia, T. Zhuang, C. Reddy, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Evolving Paradigm of Radiotherapy for High-Risk Prostate Cancer: Current Consensus and Continuing Controversies

C. Shah, A. Vassil, K. Stephans, 2016, Prostate cancer.

Contemporary Update of a Multi-Institutional Predictive Nomogram for Salvage Radiotherapy After Radical Prostatectomy.

Shree Agrawal, Daniel A Hamstra, Jeff M Michalski, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-term Follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer.

Joe Y. Chang, Anurag K. Singh, P. Iyengar, 2017, International journal of radiation oncology, biology, physics.

Salvage Radiation Therapy Dose Response for Biochemical Failure of Prostate Cancer After Prostatectomy-A Multi-Institutional Observational Study.

M. Kattan, A. Zietman, M. Anscher, 2016, International journal of radiation oncology, biology, physics.

Posttreatment Prostate-Specific Antigen 6 Months After Radiation With Androgen Deprivation Therapy Predicts for Distant Metastasis-Free Survival and Prostate Cancer-Specific Mortality.

J. Ciezki, C. Reddy, E. Klein, 2016, International journal of radiation oncology, biology, physics.

Contemporary External Beam Radiotherapy

K. Stephans, R. Tendulkar, 2012 .

Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer With Adverse Pathological Features

A. Niemierko, A. Zietman, M. Anscher, 2018, JAMA oncology.

Multi-institutional Evaluation of Elective Nodal Irradiation and/or Androgen Deprivation Therapy with Postprostatectomy Salvage Radiotherapy for Prostate Cancer.

A. Zietman, M. Anscher, J. Hearn, 2017, European urology.

Multicenter results of stereotactic body radiotherapy (SBRT) for non-resectable primary liver tumors

Charles M. Miller, J. Sanabria, K. Goodman, 2012, Acta oncologica.

Safety and efficacy of iodine-125 permanent prostate brachytherapy in patients with J-pouch anastomosis after total colectomy for ulcerative colitis.

J. Ciezki, C. Reddy, E. Klein, 2015, Practical radiation oncology.

Stereotactic body radiation therapy (SBRT) for lung cancer

K. Stephans, 2014, Applied Radiation Oncology.

Intensity-modulated radiotherapy-based stereotactic body radiotherapy for medically inoperable early-stage lung cancer: excellent local control.

Edward Clouser, C. Reddy, T. Djemil, 2010, International journal of radiation oncology, biology, physics.

The Role of Stereotactic Body Radiotherapy in the Management of Non-Small Cell Lung Cancer: An Emerging Standard for the Medically Inoperable Patient?

G. Videtic, K. Stephans, 2010, Current Oncology Reports.

A Comparison of Two Stereotactic Body Radiation Fractionation Schedules for Medically Inoperable Stage I Non-small Cell Lung Cancer: The Cleveland Clinic Experience

Tarek Mekhail, C. Reddy, P. Mazzone, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Comprehensive Analysis of Pulmonary Function Test (PFT) Changes After Stereotactic Body Radiotherapy (SBRT) for Stage I Lung Cancer in Medically Inoperable Patients

C. Reddy, P. Mazzone, T. Djemil, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Stereotactic Body Radiation Therapy for Sarcoma Pulmonary Metastases

C. Shah, G. Videtic, Kailin Yang, 2023, American journal of clinical oncology.

Multicentre results of stereotactic body radiotherapy for secondary liver tumours.

Charles M. Miller, J. Sanabria, K. Goodman, 2013, HPB : the official journal of the International Hepato Pancreato Biliary Association.

Neoadjuvant chemoradiotherapy for stage III (N2/3) non-small-cell lung cancer: a review of prospective studies

C. Robinson, K. Stephans, 2013 .

Systematic Review of Single-Fraction Stereotactic Body Radiation Therapy for Early Stage Non-Small-Cell Lung Cancer and Lung Oligometastases: How to Stop Worrying and Love One and Done

Ashutosh Kumar Singh, S. Yendamuri, G. Videtic, 2022, Cancers.

Stereotactic body radiotherapy for the treatment of oligometastatic gynecological malignancy in the abdomen and pelvis: A single-institution experience

C. Reddy, P. Rose, C. Michener, 2020, Journal of radiosurgery and SBRT.

Does motion management technique for lung SBRT influence local control? A single institutional experience comparing abdominal compression to breath-hold technique.

G. Videtic, K. Stephans, N. Woody, 2020, Practical radiation oncology.

Validation of RTOG 0813 Proximal Bronchial Tree Constraints for Pulmonary Toxicity with Stereotactic Body Radiation Therapy for Central Non-Small Cell Lung Cancer.

T. Zhuang, K. Verdecchia, G. Videtic, 2020, International journal of radiation oncology, biology, physics.

Investigation of brachial plexus dose that exceeds RTOG constraints for apical lung tumors treated with four- or five-fraction stereotactic body radiation therapy.

T. Zhuang, C. Reddy, K. Verdecchia, 2018, Journal of radiosurgery and SBRT.

Evaluation of Automated Treatment Planning and Organ Dose Prediction for Lung Stereotactic Body Radiotherapy

P. Xia, T. Zhuang, G. Videtic, 2021, Cureus.

Outpatient Anesthesia Facilitates Stereotactic Body Radiation Therapy for Early Stage Lung Cancer Patients With Advanced Cognitive Impairments

C. Reddy, G. Videtic, K. Stephans, 2019, Advances in radiation oncology.

Gantry-Mounted Linear Accelerator–Based Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer

A. Kishan, M. Scorsetti, C. Reddy, 2019, Advances in radiation oncology.

Orbital B-Cell Lymphoma

K. Stephans, Mohammad K. Khan, 2010 .

Predicting Overall Survival After Stereotactic Ablative Radiation Therapy in Early-Stage Lung Cancer: Development and External Validation of the Amsterdam Prognostic Model.

C. Reddy, S. Senan, F. Lagerwaard, 2015, International journal of radiation oncology, biology, physics.

Inter-breath-hold motion in gated cone-beam CT introducing uncertainties in image-guided radiotherapy for breath-hold treatment

P. Xia, T. Zhuang, T. Djemil, 2014, Journal of Radiation Oncology.

Ten-Year Outcomes of Moderately Hypofractionated (70 Gy in 28 fractions) Intensity Modulated Radiation Therapy for Localized Prostate Cancer.

Patrick A. Kupelian, Omar Mian, Rupesh Kotecha, 2019, International journal of radiation oncology, biology, physics.

Association of impaired heart rate recovery with cardiopulmonary complications after lung cancer resection surgery.

P. Mazzone, G. Videtic, K. McCarthy, 2015, The Journal of thoracic and cardiovascular surgery.

Prostate rotation detected from implanted markers can affect dose coverage and cannot be simply dismissed

P. Xia, K. Stephans, R. Tendulkar, 2013, Journal of applied clinical medical physics.

A phase I safety and feasibility study of neoadjuvant chemoradiation plus pembrolizumab followed by consolidation pembrolizumab in resectable stage IIIA non-small cell lung cancer.

V. Velcheti, S. Murthy, G. Videtic, 2020 .

Impact of Cribriform Pattern and Intraductal Carcinoma on Gleason 7 Prostate Cancer Treated with External Beam Radiotherapy.

J. McKenney, J. Ciezki, C. Magi-Galluzzi, 2019, The Journal of urology.

Integrating Prostate-specific Antigen Kinetics into Contemporary Predictive Nomograms of Salvage Radiotherapy After Radical Prostatectomy.

J. Hearn, D. Spratt, J. Efstathiou, 2021, European urology oncology.

A Comparison of Long-Term Treatment-Related Toxicities Between Moderately Hypofractionated and Conventionally Fractionated Radiation Therapy for Localized Prostate Cancer

J. Ciezki, C. Reddy, J. Hearn, 2014 .

Intra‐ and inter‐fractional liver and lung tumor motions treated with SBRT under active breathing control

P. Xia, T. Djemil, G. Videtic, 2017, Journal of applied clinical medical physics.

A Comparison Between Low-Dose-Rate Brachytherapy With or Without Androgen Deprivation, External Beam Radiation Therapy With or Without Androgen Deprivation, and Radical Prostatectomy With or Without Adjuvant or Salvage Radiation Therapy for High-Risk Prostate Cancer.

G. Haber, J. Ciezki, C. Reddy, 2017, International journal of radiation oncology, biology, physics.

Interobserver variability in target definition for hepatocellular carcinoma with and without portal vein thrombus: radiation therapy oncology group consensus guidelines.

T. Kim, L. Dawson, W. Bosch, 2014, International Journal of Radiation Oncology, Biology, Physics.

Prostate Cancer Screening Disparities in Persons Experiencing Homelessness

M. Phelan, O. Mian, J. Suh, 2022, JCO oncology practice.

Disparities in Prostate Cancer Diagnoses Among Persons Experiencing Homelessness.

O. Mian, M. Phelan, J. Suh, 2023, European urology.

Identifying patients with node-positive prostate cancer who may benefit from adjuvant pelvic radiation following prostatectomy.

C. Reddy, E. Klein, R. Dreicer, 2012, Journal of Clinical Oncology.

Causes of mortality after dose-escalated radiation therapy and androgen deprivation for high-risk prostate cancer.

J. Ciezki, C. Reddy, E. Klein, 2013, International journal of radiation oncology, biology, physics.

The landscape of early carcinogenesis revealed through the lens of integrative genomics, epigenomics, and transcriptomics.

M. Abazeed, O. Mian, K. Stephans, 2019, Journal of thoracic disease.

Incidental Mediastinal Nodal Radiation During Stereotactic Radiation for Lung Tumors: Implications for High-dose Treatment of Locally Advanced Disease

T. Djemil, G. Videtic, K. Stephans, 2012 .

Predicting chest wall pain from lung stereotactic body radiotherapy for different fractionation schemes.

Ping Xia, Yongbok Kim, P. Xia, 2012, International journal of radiation oncology, biology, physics.

Re-irradiation in lung cancer

A. Vassil, G. Videtic, K. Stephans, 2015, Journal of Radiation Oncology.

Identification of gene expression determinants of radiosensitivity in bladder cancer (BCa) cell lines.

G. Haber, S. Tomlins, J. Ciezki, 2018, Journal of Clinical Oncology.

A Comparison of Stereotactic Body Radiation (SBRT) Fractionation Schedules for Stage I Non-small Cell Lung Cancer (NSCLC): The Cleveland Clinic Experience

C. Reddy, T. Djemil, G. Videtic, 2008 .

Early-Stage Non–Small-Cell Lung Cancer

G. Videtic, K. Stephans, S. Kilic, 2021, Essentials of Clinical Radiation Oncology.

Twenty-year Competing Risk Analysis of Secondary Malignancies After External Beam Radiation for Postoperative Treatment of Prostate Cancer Patients From the SEER Database

J. Ciezki, C. Reddy, E. Klein, 2012 .

Online verification of breath‐hold reproducibility using kV‐triggered imaging for liver stereotactic body radiation therapy

P. Xia, B. Guo, K. Stephans, 2023, Journal of applied clinical medical physics.

Transperineal ultrasound is a good alternative for intra-fraction motion monitoring for prostate stereotactic body radiotherapy.

P. Xia, B. Guo, O. Mian, 2023, Journal of applied clinical medical physics.

Evaluation of the current prostate cancer staging system based on cancer-specific mortality in the surveillance, epidemiology, and end results database.

J. Ciezki, C. Reddy, E. Klein, 2015, Clinical genitourinary cancer.

Chest Wall Toxicity from Lung Stereotactic Body Radiotherapy (SBRT): A Dosimetric Analysis using Several Fractionation Schemes

P. Xia, T. Djemil, G. Videtic, 2010 .

Maximum standardized uptake value from staging FDG-PET/CT does not predict treatment outcome for early-stage non-small-cell lung cancer treated with stereotactic body radiotherapy.

C. Reddy, T. Djemil, G. Videtic, 2010, International journal of radiation oncology, biology, physics.

125 I Interstitial brachytherapy with or without androgen deprivation therapy among unfavorable-intermediate and high-risk prostate cancer

J. Ciezki, C. Reddy, E. Klein, 2021 .

Mortality in Men Treated With Radiation Therapy and Androgen Deprivation for High-risk Prostate Cancer in the Modern Era is Driven by Non-prostate Cancer Deaths

J. Ciezki, C. Reddy, E. Klein, 2012 .

Salvage stereotactic body radiation therapy (SBRT) for local failure after primary lung SBRT.

J. Hearn, T. Djemil, G. Videtic, 2014, International journal of radiation oncology, biology, physics.

Splenic oligometastasis: Report of a patient successfully treated with stereotactic body radiation therapy.

K. Stephans, A. Juloori, S. Parsai, 2019, Journal of Radiosurgery and SBRT.

Managing Local Recurrence After Primary Resection of Non-Small Cell Lung Cancer: The Role for Salvage Stereotactic Body Radiation Therapy

A. Vassil, G. Videtic, K. Stephans, 2016 .

Multimodality management of colorectal liver oligometastases

E. Balagamwala, K. Stephans, N. Woody, 2019, Applied Radiation Oncology.

Persistent homology derived radiomic feature predicts survival in non-small cell lung cancer patients treated with SBRT

Raoul R. Wadhwa, M. Kattan, G. Videtic, 2022 .

Outcomes in Organ Transplant Recipients With Prostate Cancer Treated With Radiotherapy

J. Ciezki, C. Reddy, K. Stephans, 2019, Clinical genitourinary cancer.

Is adaptive planning necessary for patients with large tumor position displacements observed on daily image guidance during lung SBRT?

P. Xia, G. Videtic, Saeed Ahmed, 2022, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

A Treatment Planning Study of Stereotactic Body Radiotherapy for Atrial Fibrillation

P. Tchou, P. Xia, W. Saliba, 2016, Cureus.

A Treatment Planning Study of Stereotactic Body Radiation Therapy for Atrial Fibrillation

P. Xia, W. Saliba, O. Wazni, 2015 .

Dosimetric assessment of patient‐specific breath‐hold reproducibility on liver motion for SBRT planning

P. Xia, K. Stephans, Z. Ouyang, 2020, Journal of applied clinical medical physics.

SU-F-J-141: Real-Time Position Management (RPM) System as a Valuable Tool to Predict Tumor Position Deviation in SBRT Lung and Liver Patients with Breath Hold Using Active Breathing Coordinator (ABC).

P. Xia, T. Zhuang, G. Videtic, 2016, Medical physics.

Substituting stereotactic body radiation therapy boost for brachytherapy using Mayo protocol for peri-hilar cholangiocarcinoma

K. Stephans, K. Bauer-Nilsen, S. Sittenfeld, 2019, Applied Radiation Oncology.

Ten-Year Experience in Implementing Single-Fraction Lung SBRT for Medically Inoperable Early Stage Lung Cancer.

C. Reddy, G. Videtic, K. Stephans, 2021, International journal of radiation oncology, biology, physics.

Radiation Therapy in Prostate Cancer: Defining the Benefit of Hypofractionation.

R. Kotecha, C. Shah, K. Stephans, 2016, American journal of clinical oncology.

Radiation Therapy for Cholangiocarcinoma

J. Broughman, K. Stephans, S. Campbell, 2020, Digestive Disease Interventions.

L. Minasian, E. Basch, A. Bennett, 2017, International journal of radiation oncology, biology, physics.

Outcomes for prostate glands >60 cc treated with low-dose-rate brachytherapy.

J. Ciezki, C. Reddy, E. Klein, 2016, Brachytherapy.

Long-term (potential 10-year follow-up) toxicity after treatment for prostate cancer with either external beam radiation therapy, interstitial brachytherapy, or radical prostatectomy.

J. Ciezki, C. Reddy, E. Klein, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Maximum standardized uptake value from staging FDG-PET/CT does not predict treatment outcome for early-stage non-small-cell lung cancer treated with stereotactic body radiotherapy.

C. Reddy, T. Djemil, G. Videtic, 2010, International journal of radiation oncology, biology, physics.

Never too old: A single-institution experience of stereotactic body radiation therapy for patients 90 years and older with early stage lung cancer.

C. Reddy, G. Videtic, K. Stephans, 2017, Practical radiation oncology.

Management of Brain Metastases in Patients With SCLC: Defining the Role for Stereotactic Radiosurgery

G. Barnett, C. Reddy, R. Kotecha, 2015 .